Prot. FCR001B2201 (FREEDOM-2): A single-arm, multi-center, exploratory safety and efficacy study of FCR001 cell-based therapy to induce donor-specific tolerance in previously transplanted recipients of a kidney from a living donor, and safety in FCR001don

Project: Research project

Project Details

StatusFinished
Effective start/end date8/31/21 → 8/31/24

Funding

  • CTI Clinical Trial and Consulting Services (Prot. FCR001B2201 // Prot. FCR001B2201)
  • Regenerex LLC (Prot. FCR001B2201 // Prot. FCR001B2201)